RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GALLI L
Collezione ASL Torino 4

Items : 3

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Rizzo M; Spina F; Milesi L; De Vivo R; Masini C; Merler S; Ermacora P; Verri E; Galli L; Carella C; Santini D; Buti S; Caserta C; Buttigliero C; Battelli N; Ciccarese C; Brunelli M; Iacovelli R; Sperduti I; Fornarini G; Tortora G;

First line avelumab in PD-L1+ve metastatic or locally advanced urothelial cancer (aUC) patients unfit for cisplatin (cis): The ARIES trial in Journal of Clinical Oncology

2022
ASL Torino 4

Sperduti I; Fornarini G; Masini C; Aprile G; Milesi L; Spina F; Rizzo M; Verri E; Ermacora P; Milella M; Buti S; Santini D; Naglieri E; Galli L; Battelli N; Buttigliero C; Caserta C; Ciccarese C; Brunelli M; Iacovelli R;

Complications and risk factors for severe outcome in children with measles. in Archives of disease in childhood / Arch Dis Child. 2020 Sep;105(9):896-899. doi: 10.1136/archdischild-2018-315290. Epub 2019 Jan 12.

2020
ASL Torino 4
AOU Città della Salute di Torino

Galli L; Guarino A; Villani A; Magurano F; Sala D; Bruzzese E; Di Camillo C; Pata D; Graziosi A; Govoni MR; Cambriglia MD; Mozzo E; Sacco M; Lanari M; Zavarise G; Bosis S; Cazzato S; Melzi ML; Valenzise M; Raffaldi I; Di Gangi M; Esposito S; Vecchi B; Garazzino S; Valentini P; Krzysztofiak A; Rossi N; Montagnani C; Lo Vecchio A; et alii...